TrialEuropean stroke journal2026

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial.

Louise Maes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.